Talis biomedical investor
Web5 Mar 2024 · Through the IPO, Talis Biomedical sold more than 15.8 million shares of common stock at a price of $16.00 per share. Talis Biomedical received net proceeds of approximately $232.6 million from the ... Web14 Apr 2024 · Talis Biomedical (NASDAQ:TLIS) has a market capitalization of $13.30 million and generates $4.81 million in revenue each year. The company earns $-113,010,000.00 in …
Talis biomedical investor
Did you know?
WebINVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors. GlobeNewswire. Dec-14-21 11:16AM. Insiders may be rethinking their US$6.4m Talis Biomedical Corporation (NASDAQ:TLIS) investment now that the company has lost US$27m in value. Web12 Feb 2024 · Investors of Talis Biomedical include National Institutes of Health, National Institute of Allergy and Infectious Diseases and CARB-X. Discover the right solution for your team The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology …
Web26 Jan 2024 · If you purchased or otherwise acquired Talis common stock, and/or would like to discuss your legal rights and options please visit Talis Biomedical Corporation Shareholder Class-Action Lawsuit or ... Web30 Jun 2024 · Talis Biomedical does not accept unsolicited referrals or resumes from any source other than directly from candidates or other authorized representatives. We will …
Web30 Sep 2024 · REDWOOD CITY, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity … WebTalis Biomedical Corporation; Chief Executive Officer Brian Coe; Chief Financial Officer J. Roger Moody, Jr. Director Felix Baker; Director Raymond Cheong; Director Melissa Gilliam; …
Web5 Mar 2024 · Finally, on November 15, 2024, Talis Biomedical announced that Brian Blaser was appointed as President, Chief Executive Officer, and Director of Talis Biomedical …
Web10 Apr 2024 · Talis Biomedical Competitors. $1.07 billion. -$256.75 million. 5.54. Talis Biomedical’s peers have higher revenue, but lower earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry. fest noz orvault 2023Web31 Dec 2024 · MENLO PARK, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and … fest-noz morbihanWeb10 May 2024 · Talis Biomedical has raised a total of $8.6M in funding over 1 round. This was a Grant round raised on May 10, 2024. Talis Biomedical is registered under the ticker … hpi dateWebAt Talis, we are pioneering science and technology to diagnose infectious disease rapidly, accurately, and directly at the point-of-care. Fueled by excellence and clinical rigor, we’re … fest noz morbihan 2023Web28 Feb 2024 · NEW YORK, Feb. 28, 2024 /PRNewswire/ -- WHY: New York, N.Y., February 28, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchas... fest-noz morbihan 2023Web9 Sep 2024 · Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation at [email protected] or call +1... hp ideapad 330WebAbout Talis Biomedical Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost, and rapid molecular testing for infectious diseases at the point-of-care. The company is developing the Talis One, a compact, sample-to-answer, cloud-enabled ... hpi dekalb